Menu
Recruiting NCT06650085

Protective Ileostomy Versus Protective Colostomy in Anterior Rectal Resection

No phase Interventional Stoma Colostomy Stoma Ileostomy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Loop ileostomy, Loop colostomy.
Who it may be relevant to
Registry conditions: Stoma Colostomy, Stoma Ileostomy. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

PROtective ileoStomy Versus ProtectivE Colostomy in Anterior Rectal resectIon - a Multicenter, Open-label, Randomized conTrolled studY (PROSPERITY)

Overview

Loop ileostomy and loop colostomy are both used as protective stomas after anterior resection. There is a lack of evidence on the superiority of loop ileostomy versus loop colostomy. This is a multicenter, open-label, superiority, individually randomized controlled trial including patients undergoing anterior rectal resection with primary anastomosis and a protective stoma. Patients scheduled for anterior rectal resection are randomized 1:1 to loop ileostomy or loop colostomy intraoperatively. Primary outcome is cumulative stoma-related adverse events within 60 days post-primary surgery (scored using Comprehensive Complication Index (CCI)).

Interventions

  • Procedure Loop ileostomy
    Patient undergoing anterior rectal resection will receive loop ileostomy
  • Procedure Loop colostomy
    Patient undergoing anterior rectal resection will receive loop colostomy

Primary outcome measures

  • Stoma-related adverse events [Time frame: Within 60 days from randomization]
Secondary outcome measures (5)
  • Postoperative complications [Time frame: Within 30 days from randomization]
  • Postoperative complications after stoma closure [Time frame: Within 30 days from stoma closure]
  • Hospital-free days [Time frame: Within 30 days from randomization]
  • Quality of life [Time frame: At 2 months from randomization]
  • Kidney function change [Time frame: Within 1 year from randomization]

Eligibility criteria

Inclusion Criteria: Patients undergoing anterior resection (resection of the rectum and colorectal or coloanal anastomosis) due to a rectal tumour and a protective stoma is planned.

The exclusion criteria are: (1) patient already having a stoma (or another stoma made during surgery), (2) technical inability to create ileo- or colostomy (e.g. previous bowel resection, anatomical factors), (3) age <18 years, (4) inadequate ability to co-operate.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Finland · 3 centers
  • Helsinki University Hospital — Helsinki
  • Tampere University Hospital — Tampere
  • Turku University Hospital — Turku

Publications

  • Koskenvuo L, Paajanen P, Varpe P, Seppala T, Mentula P, Haapamaki C, Carpelan-Holmstrom M, Carpelan A, Lehto K, Satokari R, Lepisto A, Sallinen V. PROtective ileoStomy versus ProtectivE colostomy in anterior Rectal resectIon: study protocol for a multicenter, open-label, randomised conTrolled studY (PROSPERITY). BMJ Open. 2025 May 6;15(5):e096091. doi: 10.1136/bmjopen-2024-096091. PMID 40335149

Identifiers

NCT: NCT06650085 · PROSPERITY

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗